MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/jac/dkac196

Медицинская библиотека · The Journal of antimicrobial chemotherapy · 2022

Isavuconazole plasma concentrations in critically ill patients during extracorporeal membrane oxygenation.

Kriegl Lisa, Hatzl Stefan, Zurl Christoph, Reisinger Alexander Christian, Schilcher Gernot, Eller Philipp, Gringschl Yvonne, Muhr Tina, Meinitzer Andreas, Prattes Juergen, Hoenigl Martin, Krause Robert

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Isavuconazole is an antifungal drug used for treatment of invasive fungal infections. Critically ill COVID-19 and influenza patients require extracorporeal membrane oxygenation (ECMO) in cases with severe acute respiratory distress syndrome and have risk factors for invasive pulmonary aspergillosis. Little is known about isavuconazole plasma concentrations during ECMO.

OBJECTIVES

To determine isavuconazole plasma concentrations in seven patients treated with intravenous isavuconazole under ECMO and the influence of the ECMO circuit immediately after the first isavuconazole dose.

METHODS

Critically ill patients treated with isavuconazole (standard doses) and ECMO were included in this study. Sixty-four blood samples used for measurement of isavuconazole concentrations were collected at several timepoints starting 2 h after the first isavuconazole dose up to 168 h. An additional 27 blood samples were drawn from the inflow and outflow line of the membrane oxygenator to assess any potential isavuconazole clearance effect of the ECMO oxygenation device and the lines.

RESULTS

Median isavuconazole trough levels above 1 μg/mL (min. 0.83, max. 1.73) or 2 μg/mL (min. 0.84, max. 2.97) were achieved 24 h or 96 h after the first dose of isavuconazole. The isavuconazole plasma concentrations pre (inflow line) and post (outflow line) the membrane oxygenator were directly correlated (ρ = 0.987, R2 = 0.994, P < 0.001). Post membrane oxygenator isavuconazole concentrations were directly correlated to contemporaneous samples obtained from the arterial lines of patients (ρ = 0.942, R2 = 0.945, P < 0.001).

CONCLUSIONS

Isavuconazole concentrations might be influenced by the higher volume of distribution due to ECMO therapy, but were not altered by the ECMO oxygenator and achieved median plasma concentrations >1 μg/mL 24 h after the first loading dose.

Для цитирования: Kriegl Lisa, Hatzl Stefan, Zurl Christoph, Reisinger Alexander Christian, Schilcher Gernot, Eller Philipp, Gringschl Yvonne, Muhr Tina, Meinitzer Andreas, Prattes Juergen, Hoenigl Martin, Krause Robert. Isavuconazole plasma concentrations in critically ill patients during extracorporeal membrane oxygenation.. The Journal of antimicrobial chemotherapy. 2022. DOI: 10.1093/jac/dkac196.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.